Global Veterinary Therapeutics Market Insights, Forecast to 2025
- QYR2795710
- 118 Pages
- October 2018
- Pharmaceuticals
This report studies the global market size of Veterinary Therapeutics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Veterinary Therapeutics in these regions.
This research report categorizes the global Veterinary Therapeutics market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.
The various contributors involved in the value chain of Veterinary Therapeutics include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Veterinary Therapeutics include
Bayer AG
Boehringer Ingelheim GmbH
Ceva Sante Animale
Dechra Pharmaceuticals PLC
Eli Lilly and Company (Elanco Animal Health)
Merck Animal Health
Sanofi (Merial Animal Health)
Virbac
Vetoquinol S.A.
Zoetis, Inc.
Market Size Split by Type
By Drugs
Anti-inflammatory
Parasiticides
Other
By Vaccines
Inactivated Vaccines
Live Attenuated Vaccines
Recombinant Vaccines
By Medicated Feed Additives
Amino Acids
Antibiotics
Market Size Split by Application
Hospitals
Veterinary Clinics
Drug Stores
Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Veterinary Therapeutics market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Veterinary Therapeutics market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Veterinary Therapeutics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Veterinary Therapeutics with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Veterinary Therapeutics submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Veterinary Therapeutics are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Veterinary Therapeutics market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 Study Coverage
1.1 Veterinary Therapeutics Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Veterinary Therapeutics Market Size Growth Rate by Type
1.4.2 Anti-inflammatory
1.4.3 Parasiticides
1.4.4 Other
1.5 Market by Application
1.5.1 Global Veterinary Therapeutics Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Veterinary Clinics
1.5.4 Drug Stores
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Veterinary Therapeutics Market Size
2.1.1 Global Veterinary Therapeutics Revenue 2016-2025
2.1.2 Global Veterinary Therapeutics Sales 2016-2025
2.2 Veterinary Therapeutics Growth Rate by Regions
2.2.1 Global Veterinary Therapeutics Sales by Regions
2.2.2 Global Veterinary Therapeutics Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Veterinary Therapeutics Sales by Manufacturers
3.1.1 Veterinary Therapeutics Sales by Manufacturers
3.1.2 Veterinary Therapeutics Sales Market Share by Manufacturers
3.1.3 Global Veterinary Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Veterinary Therapeutics Revenue by Manufacturers
3.2.1 Veterinary Therapeutics Revenue by Manufacturers (2016-2018)
3.2.2 Veterinary Therapeutics Revenue Share by Manufacturers (2016-2018)
3.3 Veterinary Therapeutics Price by Manufacturers
3.4 Veterinary Therapeutics Manufacturing Base Distribution, Product Types
3.4.1 Veterinary Therapeutics Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Veterinary Therapeutics Product Category
3.4.3 Date of International Manufacturers Enter into Veterinary Therapeutics Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global Veterinary Therapeutics Sales by Type
4.2 Global Veterinary Therapeutics Revenue by Type
4.3 Veterinary Therapeutics Price by Type
5 Breakdown Data by Application
5.1 Overview
5.2 Global Veterinary Therapeutics Breakdown Data by Application
6 North America
6.1 North America Veterinary Therapeutics by Countries
6.1.1 North America Veterinary Therapeutics Sales by Countries
6.1.2 North America Veterinary Therapeutics Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Veterinary Therapeutics by Type
6.3 North America Veterinary Therapeutics by Application
6.4 North America Veterinary Therapeutics by Company
7 Europe
7.1 Europe Veterinary Therapeutics by Countries
7.1.1 Europe Veterinary Therapeutics Sales by Countries
7.1.2 Europe Veterinary Therapeutics Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Veterinary Therapeutics by Type
7.3 Europe Veterinary Therapeutics by Application
7.4 Europe Veterinary Therapeutics by Company
8 Asia Pacific
8.1 Asia Pacific Veterinary Therapeutics by Countries
8.1.1 Asia Pacific Veterinary Therapeutics Sales by Countries
8.1.2 Asia Pacific Veterinary Therapeutics Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Veterinary Therapeutics by Type
8.3 Asia Pacific Veterinary Therapeutics by Application
8.4 Asia Pacific Veterinary Therapeutics by Company
9 Central & South America
9.1 Central & South America Veterinary Therapeutics by Countries
9.1.1 Central & South America Veterinary Therapeutics Sales by Countries
9.1.2 Central & South America Veterinary Therapeutics Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Veterinary Therapeutics by Type
9.3 Central & South America Veterinary Therapeutics by Application
9.4 Central & South America Veterinary Therapeutics by Company
10 Middle East and Africa
10.1 Middle East and Africa Veterinary Therapeutics by Countries
10.1.1 Middle East and Africa Veterinary Therapeutics Sales by Countries
10.1.2 Middle East and Africa Veterinary Therapeutics Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Veterinary Therapeutics by Type
10.3 Middle East and Africa Veterinary Therapeutics by Application
10.4 Middle East and Africa Veterinary Therapeutics by Company
11 Company Profiles
11.1 Bayer AG
11.1.1 Bayer AG Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Veterinary Therapeutics
11.1.4 Veterinary Therapeutics Product Description
11.1.5 Recent Development
11.2 Boehringer Ingelheim GmbH
11.2.1 Boehringer Ingelheim GmbH Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Veterinary Therapeutics
11.2.4 Veterinary Therapeutics Product Description
11.2.5 Recent Development
11.3 Ceva Sante Animale
11.3.1 Ceva Sante Animale Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Veterinary Therapeutics
11.3.4 Veterinary Therapeutics Product Description
11.3.5 Recent Development
11.4 Dechra Pharmaceuticals PLC
11.4.1 Dechra Pharmaceuticals PLC Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Veterinary Therapeutics
11.4.4 Veterinary Therapeutics Product Description
11.4.5 Recent Development
11.5 Eli Lilly and Company (Elanco Animal Health)
11.5.1 Eli Lilly and Company (Elanco Animal Health) Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Veterinary Therapeutics
11.5.4 Veterinary Therapeutics Product Description
11.5.5 Recent Development
11.6 Merck Animal Health
11.6.1 Merck Animal Health Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Veterinary Therapeutics
11.6.4 Veterinary Therapeutics Product Description
11.6.5 Recent Development
11.7 Sanofi (Merial Animal Health)
11.7.1 Sanofi (Merial Animal Health) Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Veterinary Therapeutics
11.7.4 Veterinary Therapeutics Product Description
11.7.5 Recent Development
11.8 Virbac
11.8.1 Virbac Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Veterinary Therapeutics
11.8.4 Veterinary Therapeutics Product Description
11.8.5 Recent Development
11.9 Vetoquinol S.A.
11.9.1 Vetoquinol S.A. Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Veterinary Therapeutics
11.9.4 Veterinary Therapeutics Product Description
11.9.5 Recent Development
11.10 Zoetis, Inc.
11.10.1 Zoetis, Inc. Company Details
11.10.2 Company Description
11.10.3 Sales, Revenue and Gross Margin of Veterinary Therapeutics
11.10.4 Veterinary Therapeutics Product Description
11.10.5 Recent Development
12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators
13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Veterinary Therapeutics Raw Material
13.1.2 Veterinary Therapeutics Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer
Figure Picture of Veterinary Therapeutics
Figure Global Veterinary Therapeutics Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Veterinary Therapeutics Production Market Share by Types (Product Category) in 2017
Figure Anti-inflammatory Product Picture
Table Major Manufacturers of Anti-inflammatory
Figure Parasiticides Product Picture
Table Major Manufacturers of Parasiticides
Figure Other Product Picture
Table Major Manufacturers of Other
Table Global Veterinary Therapeutics Market Size Growth Rate by Application 2018-2025 (K Units)
Figure Hospitals
Figure Veterinary Clinics
Figure Drug Stores
Figure Veterinary Therapeutics Report Years Considered
Figure Global Veterinary Therapeutics Market Size 2016-2025 (Million US$)
Figure Global Veterinary Therapeutics Sales 2016-2025 (K Units)
Table Global Veterinary Therapeutics Market Size by Regions 2016-2025 (K Units) & (Million US$)
Table Global Veterinary Therapeutics Sales by Regions 2016-2025 (K Units)
Table Global Veterinary Therapeutics Sales Market Share by Regions 2016-2025
Figure Global Veterinary Therapeutics Sales Market Share by Regions 2016-2025
Figure 2017 Global Veterinary Therapeutics Sales Market Share by Regions
Table Global Veterinary Therapeutics Revenue by Regions 2016-2025 (Million US$)
Table Global Veterinary Therapeutics Revenue Market Share by Regions 2016-2025
Figure Global Veterinary Therapeutics Revenue Market Share by Regions 2016-2025
Figure 2017 Global Veterinary Therapeutics Revenue Market Share by Regions
Table Global Veterinary Therapeutics Sales by Manufacturers (2016-2018) (K Units)
Table Global Veterinary Therapeutics Sales Share by Manufacturers (2016-2018)
Figure Global Veterinary Therapeutics Sales Share by Manufacturers in 2017
Table Veterinary Therapeutics Revenue by Manufacturers (2016-2018) (Million US$)
Table Veterinary Therapeutics Revenue Share by Manufacturers (2016-2018)
Figure Veterinary Therapeutics Value Share by Manufacturers in 2017
Table Global Veterinary Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Veterinary Therapeutics Price (2016-2018) (USD/Unit)
Table Veterinary Therapeutics Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Veterinary Therapeutics Product Category
Table Date of International Manufacturers Enter into Veterinary Therapeutics Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Veterinary Therapeutics Sales by Type (2016-2025) (K Units)
Table Global Veterinary Therapeutics Sales Share by Type (2016-2025)
Figure Global Veterinary Therapeutics Sales Market Share by Type (2016-2025)
Figure Global Veterinary Therapeutics Sales Market Share by Type in 2017
Table Global Veterinary Therapeutics Revenue by Type (2016-2025) (Million US$)
Table Global Veterinary Therapeutics Revenue Share by Type (2016-2025)
Figure Global Veterinary Therapeutics Revenue Market Share by Type (2016-2025)
Figure Global Veterinary Therapeutics Revenue Market Share by Type in 2017
Table Veterinary Therapeutics Price by Type 2013-2018 (USD/Unit)
Table Global Veterinary Therapeutics Sales by Application (2016-2025) (K Units)
Table Global Veterinary Therapeutics Sales Share by Application (2016-2025)
Figure Global Sales Veterinary Therapeutics Market Share by Application (2016-2025)
Figure Global Sales Veterinary Therapeutics Market Share by Application (2016-2025)
Figure North America Veterinary Therapeutics Sales Growth Rate 2016-2025 (K Units)
Figure North America Veterinary Therapeutics Revenue Growth Rate 2016-2025 (Million US$)
Table North America Veterinary Therapeutics Sales by Countries (2016-2025) (K Units)
Table North America Veterinary Therapeutics Sales Market Share by Countries (2016-2025)
Figure 2017 North America Veterinary Therapeutics Sales Market Share by Countries
Table North America Veterinary Therapeutics Revenue by Countries (2016-2025) (Million US$)
Table North America Veterinary Therapeutics Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Veterinary Therapeutics Revenue Market Share by Countries
Figure United States Veterinary Therapeutics Sales Growth Rate (2016-2025) (K Units)
Figure United States Veterinary Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Veterinary Therapeutics Sales Growth Rate (2016-2025) (K Units)
Figure Canada Veterinary Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Veterinary Therapeutics Sales Growth Rate (2016-2025) (K Units)
Figure Mexico Veterinary Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
Table North America Veterinary Therapeutics Sales by Type (2016-2025) (K Units)
Table North America Veterinary Therapeutics Sales Market Share by Type (2016-2025)
Figure 2017 North America Veterinary Therapeutics Market Share by Type
Table North America Veterinary Therapeutics Sales by Application (2016-2025) (K Units)
Table North America Veterinary Therapeutics Sales Market Share by Application (2016-2025)
Figure 2017 North America Veterinary Therapeutics Market Share by Application
Table North America Veterinary Therapeutics Sales by Company (2016-2018) (K Units)
Table North America Veterinary Therapeutics Sales Market Share by Company (2016-2018)
Figure North America Veterinary Therapeutics Sales Market Share by Company in 2017
Figure Europe Veterinary Therapeutics Sales Growth Rate 2016-2025 (K Units)
Figure Europe Veterinary Therapeutics Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Veterinary Therapeutics Sales by Countries (2016-2025) (K Units)
Table Europe Veterinary Therapeutics Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Veterinary Therapeutics Sales Market Share by Countries
Table Europe Veterinary Therapeutics Revenue by Countries (2016-2025) (Million US$)
Table Europe Veterinary Therapeutics Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Veterinary Therapeutics Revenue Market Share by Countries
Figure Germany Veterinary Therapeutics Sales Growth Rate (2016-2025) (K Units)
Figure Germany Veterinary Therapeutics Revenue Growth Rate (2016-2025) (K Units)
Figure France Veterinary Therapeutics Sales Growth Rate (2016-2025) (K Units)
Figure France Veterinary Therapeutics Revenue Growth Rate (2016-2025) (K Units)
Figure UK Veterinary Therapeutics Sales Growth Rate (2016-2025) (K Units)
Figure UK Veterinary Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Veterinary Therapeutics Sales Growth Rate (2016-2025) (K Units)
Figure Italy Veterinary Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Veterinary Therapeutics Sales Growth Rate (2016-2025) (K Units)
Figure Russia Veterinary Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Veterinary Therapeutics Sales by Type (2016-2025) (K Units)
Table Europe Veterinary Therapeutics Sales Market Share by Type (2016-2025)
Figure 2017 Europe Veterinary Therapeutics Market Share by Type
Table Europe Veterinary Therapeutics Sales by Application (2016-2025) (K Units)
Table Europe Veterinary Therapeutics Sales Market Share by Application (2016-2025)
Figure 2017 Europe Veterinary Therapeutics Market Share by Application
Table Europe Veterinary Therapeutics Sales by Company (2016-2018) (K Units)
Table Europe Veterinary Therapeutics Sales Market Share by Company (2016-2018)
Figure Europe Veterinary Therapeutics Sales Market Share by Company in 2017
Figure Asia Pacific Veterinary Therapeutics Sales Growth Rate 2016-2025 (K Units)
Figure Asia Pacific Veterinary Therapeutics Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Veterinary Therapeutics Sales by Countries (2016-2025) (K Units)
Table Asia Pacific Veterinary Therapeutics Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Veterinary Therapeutics Sales Market Share by Countries
Table Asia Pacific Veterinary Therapeutics Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Veterinary Therapeutics Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Veterinary Therapeutics Revenue Market Share by Countries
Figure China Veterinary Therapeutics Sales Growth Rate (2016-2025) (K Units)
Figure China Veterinary Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Veterinary Therapeutics Sales Growth Rate (2016-2025) (K Units)
Figure Japan Veterinary Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Veterinary Therapeutics Sales Growth Rate (2016-2025) (K Units)
Figure Korea Veterinary Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
Figure India Veterinary Therapeutics Sales Growth Rate (2016-2025) (K Units)
Figure India Veterinary Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Veterinary Therapeutics Sales Growth Rate (2016-2025) (K Units)
Figure Australia Veterinary Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Veterinary Therapeutics Sales Growth Rate (2016-2025) (K Units)
Figure Indonesia Veterinary Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Veterinary Therapeutics Sales Growth Rate (2016-2025) (K Units)
Figure Malaysia Veterinary Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Veterinary Therapeutics Sales Growth Rate (2016-2025) (K Units)
Figure Philippines Veterinary Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Veterinary Therapeutics Sales Growth Rate (2016-2025) (K Units)
Figure Thailand Veterinary Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Veterinary Therapeutics Sales Growth Rate (2016-2025) (K Units)
Figure Vietnam Veterinary Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Veterinary Therapeutics Sales Growth Rate (2016-2025) (K Units)
Figure Singapore Veterinary Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Veterinary Therapeutics Sales by Type (2016-2025) (K Units)
Table Asia Pacific Veterinary Therapeutics Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Veterinary Therapeutics Market Share by Type
Table Asia Pacific Veterinary Therapeutics Sales by Application (2016-2025) (K Units)
Table Asia Pacific Veterinary Therapeutics Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Veterinary Therapeutics Market Share by Application
Table Asia Pacific Veterinary Therapeutics Sales by Company (2016-2018) (K Units)
Table Asia Pacific Veterinary Therapeutics Sales Market Share by Company (2016-2018)
Figure Asia Pacific Veterinary Therapeutics Sales Market Share by Company in 2017
Figure Central & South America Veterinary Therapeutics Sales Growth Rate 2016-2025 (K Units)
Figure Central & South America Veterinary Therapeutics Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Veterinary Therapeutics Sales by Countries (2016-2025) (K Units)
Table Central & South America Veterinary Therapeutics Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Veterinary Therapeutics Sales Market Share by Countries
Table Central & South America Veterinary Therapeutics Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Veterinary Therapeutics Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Veterinary Therapeutics Revenue Market Share by Countries
Figure Brazil Veterinary Therapeutics Sales Growth Rate (2016-2025) (K Units)
Figure Brazil Veterinary Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Veterinary Therapeutics Sales Growth Rate (2016-2025) (K Units)
Figure Argentina Veterinary Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Veterinary Therapeutics Sales by Type (2016-2025) (K Units)
Table Central & South America Veterinary Therapeutics Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Veterinary Therapeutics Market Share by Type
Table Central & South America Veterinary Therapeutics Sales by Application (2016-2025) (K Units)
Table Central & South America Veterinary Therapeutics Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Veterinary Therapeutics Market Share by Application
Table Central & South America Veterinary Therapeutics Sales by Company (2016-2018) (K Units)
Table Central & South America Veterinary Therapeutics Sales Market Share by Company (2016-2018)
Figure Central & South America Veterinary Therapeutics Sales Market Share by Company in 2017
Figure Middle East and Africa Veterinary Therapeutics Sales Growth Rate 2016-2025 (K Units)
Figure Middle East and Africa Veterinary Therapeutics Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Veterinary Therapeutics Sales by Countries (2016-2025) (K Units)
Table Middle East and Africa Veterinary Therapeutics Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Veterinary Therapeutics Sales Market Share by Countries
Table Middle East and Africa Veterinary Therapeutics Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Veterinary Therapeutics Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Veterinary Therapeutics Revenue Market Share by Countries
Figure GCC Countries Veterinary Therapeutics Sales Growth Rate (2016-2025) (K Units)
Figure GCC Countries Veterinary Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Veterinary Therapeutics Sales Growth Rate (2016-2025) (K Units)
Figure Turkey Veterinary Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Veterinary Therapeutics Sales Growth Rate (2016-2025) (K Units)
Figure Egypt Veterinary Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Veterinary Therapeutics Sales Growth Rate (2016-2025) (K Units)
Figure South Africa Veterinary Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Veterinary Therapeutics Sales by Type (2016-2025) (K Units)
Table Middle East and Africa Veterinary Therapeutics Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Veterinary Therapeutics Market Share by Type
Table Middle East and Africa Veterinary Therapeutics Sales by Application (2016-2025) (K Units)
Table Middle East and Africa Veterinary Therapeutics Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Veterinary Therapeutics Market Share by Application
Table Middle East and Africa Veterinary Therapeutics Sales by Company (2016-2018) (K Units)
Table Middle East and Africa Veterinary Therapeutics Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Veterinary Therapeutics Sales Market Share by Company in 2017
Table Bayer AG Company Details
Table Bayer AG Veterinary Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Bayer AG Recent Development
Table Boehringer Ingelheim GmbH Company Details
Table Boehringer Ingelheim GmbH Veterinary Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Boehringer Ingelheim GmbH Recent Development
Table Ceva Sante Animale Company Details
Table Ceva Sante Animale Veterinary Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Ceva Sante Animale Recent Development
Table Dechra Pharmaceuticals PLC Company Details
Table Dechra Pharmaceuticals PLC Veterinary Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Dechra Pharmaceuticals PLC Recent Development
Table Eli Lilly and Company (Elanco Animal Health) Company Details
Table Eli Lilly and Company (Elanco Animal Health) Veterinary Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Eli Lilly and Company (Elanco Animal Health) Recent Development
Table Merck Animal Health Company Details
Table Merck Animal Health Veterinary Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Merck Animal Health Recent Development
Table Sanofi (Merial Animal Health) Company Details
Table Sanofi (Merial Animal Health) Veterinary Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Sanofi (Merial Animal Health) Recent Development
Table Virbac Company Details
Table Virbac Veterinary Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Virbac Recent Development
Table Vetoquinol S.A. Company Details
Table Vetoquinol S.A. Veterinary Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Vetoquinol S.A. Recent Development
Table Zoetis, Inc. Company Details
Table Zoetis, Inc. Veterinary Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Zoetis, Inc. Recent Development
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Veterinary Therapeutics Value Chain
Table Typical Suppliers of Key Veterinary Therapeutics Raw Material
Table Veterinary Therapeutics Customers List
Table Veterinary Therapeutics Sales Channels
Table Veterinary Therapeutics Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
